Immatics (IMTX) EBT Margin (2019 - 2025)

Immatics' (IMTX) quarterly EBT Margin came in at 179.97% in Q4 2025, down 31070.0% year-on-year from N/an in Q4 2024, and up 81.58% quarter-over-quarter from 976.9% in Q3 2025.

Immatics (IMTX) EBT Margin (2019 - 2025) Analysis & Trends

Immatics has disclosed EBT Margin across 7 years of filings, most recently posting 179.97% for Q4 2025.

  • EBT Margin for Q4 2025 came in at 179.97%, down 31070.0% year-over-year; the trailing twelve-month figure through Dec 2025 was 415.69% (down 43592.0% YoY), and the FY2025 annual result was 411.13%, down 42483.0% from the prior year.
  • EBT Margin came in at 179.97% for Q4 2025 at Immatics, up from 976.9% in the prior quarter.
  • In the past five years, EBT Margin ranged from a high of 130.73% in Q4 2024 to a low of 1506.21% in Q2 2025.
  • The 5-year median for EBT Margin is 149.77% (2022), against an average of 264.5%.
  • Across the five-year window, EBT Margin surged 166083 bps in 2021 and plunged 141102 bps in 2025, its largest moves.
  • Immatics' EBT Margin stood at 106.74% in 2021, then surged by 74 bps to 27.66% in 2022, then sank by 494 bps to 164.24% in 2023, then jumped by 180 bps to 130.73% in 2024, then plunged by 238 bps to 179.97% in 2025.
  • The last three EBT Margin figures came in at 179.97% (Q4 2025), 976.9% (Q3 2025), and 1506.21% (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 6.40%
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 41.95%
9 Abivax 91.96 Bn 91.96 Bn - -
10 Immatics 14.67 Bn 14.67 Bn - -179.97%

Historic Data

Download Data
DateValue
Dec 31, 2025 -179.97%
Sep 30, 2025 -976.90%
Jun 30, 2025 -1,506.21%
Mar 31, 2025 -219.83%
Dec 31, 2024 130.73%
Sep 30, 2024 -11.20%
Jun 30, 2024 -95.19%
Mar 31, 2024 -5.69%
Dec 31, 2023 -164.24%
Sep 30, 2023 -447.00%
Jun 30, 2023 -110.09%
Mar 31, 2023 -201.58%
Dec 31, 2022 -27.66%
Sep 30, 2022 -135.31%
Jun 30, 2022 -74.56%
Mar 31, 2022 83.24%
Dec 31, 2021 -106.74%
Sep 30, 2021 -422.21%
Jun 30, 2021 -511.35%
Mar 31, 2021 -308.16%